170 related articles for article (PubMed ID: 25724656)
1. Effects of ghrelin treatment on exertional dyspnea in COPD: an exploratory analysis.
Miki K; Maekura R; Nagaya N; Miki M; Kitada S; Yoshimura K; Mori M; Kangawa K
J Physiol Sci; 2015 May; 65(3):277-84. PubMed ID: 25724656
[TBL] [Abstract][Full Text] [Related]
2. Effects of ghrelin treatment on exercise capacity in underweight COPD patients: a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment.
Miki K; Maekura R; Nagaya N; Kitada S; Miki M; Yoshimura K; Tateishi Y; Motone M; Hiraga T; Mori M; Kangawa K
BMC Pulm Med; 2013 Jun; 13():37. PubMed ID: 23758800
[TBL] [Abstract][Full Text] [Related]
3. Randomized, dose-finding trial of ghrelin treatment for chronic respiratory failure.
Miki K; Maekura R; Nakazato M; Matsumoto N; Kitada S; Miki M; Yoshimura K; Mori M; Kangawa K
Clin Respir J; 2017 Jul; 11(4):496-505. PubMed ID: 26260705
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary rehabilitation for COPD improves exercise time rather than exercise tolerance: effects and mechanisms.
Miki K; Maekura R; Kitada S; Miki M; Yoshimura K; Yamamoto H; Kawabe T; Kagawa H; Oshitani Y; Satomi A; Nishida K; Sawa N; Inoue K
Int J Chron Obstruct Pulmon Dis; 2017; 12():1061-1070. PubMed ID: 28435239
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Gas Exchange Abnormalities in Mild Chronic Obstructive Pulmonary Disease. Implications for Dyspnea and Exercise Intolerance.
Elbehairy AF; Ciavaglia CE; Webb KA; Guenette JA; Jensen D; Mourad SM; Neder JA; O'Donnell DE;
Am J Respir Crit Care Med; 2015 Jun; 191(12):1384-94. PubMed ID: 25826478
[TBL] [Abstract][Full Text] [Related]
6. Relieving exertional dyspnea during the 3-min constant speed shuttle test in patients with COPD with indacaterol/glycopyrronium
Beaulieu J; Jensen D; O'Donnell DE; Brouillard C; Tracey L; Vincent S; Nadreau É; Bernard E; Bernard S; Maltais F
Ther Adv Respir Dis; 2020; 14():1753466620939507. PubMed ID: 32663102
[TBL] [Abstract][Full Text] [Related]
7. Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.
Ambrosino N; Foglio K; Balzano G; Paggiaro PL; Lessi P; Kesten S;
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):771-80. PubMed ID: 19281092
[TBL] [Abstract][Full Text] [Related]
8. Excess Ventilation in Chronic Obstructive Pulmonary Disease-Heart Failure Overlap. Implications for Dyspnea and Exercise Intolerance.
Rocha A; Arbex FF; Sperandio PA; Souza A; Biazzim L; Mancuso F; Berton DC; Hochhegger B; Alencar MCN; Nery LE; O'Donnell DE; Neder JA
Am J Respir Crit Care Med; 2017 Nov; 196(10):1264-1274. PubMed ID: 28665692
[TBL] [Abstract][Full Text] [Related]
9. Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial.
Beeh KM; Watz H; Puente-Maestu L; de Teresa L; Jarreta D; Caracta C; Garcia Gil E; Magnussen H
BMC Pulm Med; 2014 Dec; 14():209. PubMed ID: 25539654
[TBL] [Abstract][Full Text] [Related]
10. A phase II, open-label clinical trial on the combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary disease.
Miki K; Kitada S; Miki M; Hui SP; Shrestha R; Yoshimura K; Tsujino K; Kagawa H; Oshitani Y; Kida H; Maekura R; Kangawa K
J Physiol Sci; 2019 Nov; 69(6):969-979. PubMed ID: 31595463
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial.
Miki K; Maekura R; Nagaya N; Nakazato M; Kimura H; Murakami S; Ohnishi S; Hiraga T; Miki M; Kitada S; Yoshimura K; Tateishi Y; Arimura Y; Matsumoto N; Yoshikawa M; Yamahara K; Kangawa K
PLoS One; 2012; 7(5):e35708. PubMed ID: 22563468
[TBL] [Abstract][Full Text] [Related]
12. Effects of oxygen on exertional dyspnoea and exercise performance in patients with chronic obstructive pulmonary disease.
Miki K; Maekura R; Hiraga T; Kitada S; Miki M; Yoshimura K; Tateishi Y
Respirology; 2012 Jan; 17(1):149-54. PubMed ID: 22008208
[TBL] [Abstract][Full Text] [Related]
13. Ghrelin administration for chronic respiratory failure: a randomized dose-comparison trial.
Matsumoto N; Miki K; Tsubouchi H; Sakamoto A; Arimura Y; Yanagi S; Iiboshi H; Yoshida M; Souma R; Ishimoto H; Yamamoto Y; Yatera K; Yoshikawa M; Sagara H; Iwanaga T; Mukae H; Maekura R; Kimura H; Nakazato M; Kangawa K
Lung; 2015 Apr; 193(2):239-47. PubMed ID: 25634352
[TBL] [Abstract][Full Text] [Related]
14. Acute bronchodilator therapy does not reduce wasted ventilation during exercise in COPD.
Elbehairy AF; Webb KA; Laveneziana P; Domnik NJ; Neder JA; O'Donnell DE;
Respir Physiol Neurobiol; 2018 Jun; 252-253():64-71. PubMed ID: 29578103
[TBL] [Abstract][Full Text] [Related]
15. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD.
O'Donnell DE; Hamilton AL; Webb KA
J Appl Physiol (1985); 2006 Oct; 101(4):1025-35. PubMed ID: 16675610
[TBL] [Abstract][Full Text] [Related]
16. Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD.
Borel B; Wilkinson-Maitland CA; Hamilton A; Bourbeau J; Perrault H; Jensen D; Maltais F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2991-3000. PubMed ID: 27942208
[TBL] [Abstract][Full Text] [Related]
17. Ventilatory Inefficiency and Exertional Dyspnea in Early Chronic Obstructive Pulmonary Disease.
Neder JA; Berton DC; Müller PT; Elbehairy AF; Rocha A; Palange P; O'Donnell DE;
Ann Am Thorac Soc; 2017 Jul; 14(Supplement_1):S22-S29. PubMed ID: 28345959
[TBL] [Abstract][Full Text] [Related]
18. Effect of fluticasone/salmeterol combination on dyspnea and respiratory mechanics in mild-to-moderate COPD.
Guenette JA; Webb KA; O'Donnell DE
Respir Med; 2013 May; 107(5):708-16. PubMed ID: 23421968
[TBL] [Abstract][Full Text] [Related]
19. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study.
Wang C; Sun T; Huang Y; Humphries M; Bai L; Li L; Wang Q; Kho P; Firth R; D'Andrea P
Int J Chron Obstruct Pulmon Dis; 2015; 10():57-68. PubMed ID: 25609940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
